M
Maaike De Crop
Researcher at Institute of Tropical Medicine Antwerp
Publications - 12
Citations - 282
Maaike De Crop is an academic researcher from Institute of Tropical Medicine Antwerp. The author has contributed to research in topics: Pregnancy & Randomized controlled trial. The author has an hindex of 10, co-authored 12 publications receiving 242 citations.
Papers
More filters
Journal ArticleDOI
Four artemisinin-based treatments in African pregnant women with malaria.
Divine Pekyi,Akua A. Ampromfi,Halidou Tinto,Maminata Traoré-Coulibaly,Marc Christian Tahita,Innocent Valea,Victor Mwapasa,Linda Kalilani-Phiri,Gertrude Kalanda,Mwayiwawo Madanitsa,Raffaella Ravinetto,Theonest K. Mutabingwa,Prosper Gbekor,Harry Tagbor,Gifty Antwi,Joris Menten,Maaike De Crop,Yves Claeys,Céline Schurmans,Chantal Van Overmeir,Kamala Thriemer,Jean-Pierre Van Geertruyden,Umberto D'Alessandro,Michael Nambozi,Modest Mulenga,Sebastian Hachizovu,Jean-Bertin Bukasa Kabuya,Joyce Mulenga +27 more
TL;DR: Artemether-lumefantrine was associated with the fewest adverse effects and with acceptable cure rates but provided the shortest posttreatment prophylaxis, whereas dihydroartemisinin-piperaquine had the best efficacy and an acceptable safety profile.
Journal ArticleDOI
Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study.
Ermias Diro,Koert Ritmeijer,Marleen Boelaert,Fabiana Alves,Rezika Mohammed,Charles Abongomera,Raffaella Ravinetto,Maaike De Crop,Helina Fikre,Cherinet Adera,Robert Colebunders,Harry van Loen,Joris Menten,Lutgarde Lynen,Asrat Hailu,Johan van Griensven +15 more
TL;DR: Pentamidine secondary prophylaxis led to a 29% failure rate within one year, much lower than reported in historical controls (50%-100%).
Journal ArticleDOI
The assessment of gestational age: a comparison of different methods from a malaria pregnancy cohort in sub-Saharan Africa.
Holger W. Unger,Holger W. Unger,Kamala Thriemer,Benedikt Ley,Halidou Tinto,Maminata Traore,Innocent Valea,Harry Tagbor,Gifty Antwi,Prosper Gbekor,Michael Nambozi,Jean-Bertin Bukasa Kabuya,Modest Mulenga,Victor Mwapasa,Gertrude Chapotera,Mwayiwawo Madanitsa,Stephen Rulisa,Maaike De Crop,Yves Claeys,Raffaella Ravinetto,Umberto D'Alessandro +20 more
TL;DR: In settings with limited access to ultrasound, and in women who had been treated with P. falciparum malaria, SFH may be the most useful antenatal tool to date a pregnancy when women present first in second and third trimester.
Journal ArticleDOI
Long-term Clinical Outcomes in Visceral Leishmaniasis/Human Immunodeficiency Virus–Coinfected Patients During and After Pentamidine Secondary Prophylaxis in Ethiopia: A Single-Arm Clinical Trial
Ermias Diro,Ermias Diro,Koert Ritmeijer,Marleen Boelaert,Fabiana Alves,Rezika Mohammed,Charles Abongomera,Raffaella Ravinetto,Maaike De Crop,Helina Fikre,Cherinet Adera,Harry van Loen,Achilleas Tsoumanis,Wim Adriaensen,Asrat Hailu,Johan van Griensven +15 more
TL;DR: Patients reaching a CD4 count >200 cells/µL after 12 months of prophylaxis can safely discontinue pentamidine and the 2-year risk of relapse was 37%.
Journal ArticleDOI
Design and Analysis Considerations in the Ebola_Tx Trial Evaluating Convalescent Plasma in the Treatment of Ebola Virus Disease in Guinea During the 2014-2015 Outbreak
Tansy Edwards,Malcolm G Semple,Anja De Weggheleire,Yves Claeys,Maaike De Crop,Joris Menten,Raffaella Ravinetto,Sarah Temmerman,Lutgarde Lynen,Elhadj Ibrahima Bah,Pete Smith,Johan van Griensven +11 more
TL;DR: Evaluation of treatment with convalescent plasma from Ebola survivors in an emergency setting, where randomization was unacceptable, concluded that per-protocol and intention-to-treat approaches gave similar conclusions.